TickerFactsScreenerDevelopers

Theriva Biologics, Inc. (TOVX) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2011: $7.06M2012: $13.03M2013: $15.23M2014: $9.56M2015: $15.00M2016: $2.26M2017: -$3.41M2018: $14.16M2019: -$1.06M2020: -$7.54M2021: $65.41M2022: $51.83M2023: $36.96M2024: $19.07M2025: $15.38M$15.38M
2011Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$15.38M-19.3%
2024$19.07M-48.4%
2023$36.96M-28.7%
2022$51.83M-20.8%
2021$65.41M+967.5%
2020-$7.54M-613.3%
2019-$1.06M-107.5%
2018$14.16M+515.2%
2017-$3.41M-250.8%
2016$2.26M-84.9%
2015$15.00M+57.0%
2014$9.56M-37.3%
2013$15.23M+16.9%
2012$13.03M+84.6%
2011$7.06M—